-
PEGylated Iron Oxide Nanoparticles in the Liver
2026-09-17
This ACS Nano study systematically examines how iron oxide nanoparticle size and PEG chain length shape hepatic distribution and uptake across major liver cell populations. Its combination of 99mTc-SPECT/CT imaging with primary-cell assays challenges the assumption that Kupffer cells dominate nanoparticle clearance and identifies 2K PEG as a potentially favorable balance between circulation and reduced liver sequestration.
-
HyperScribe T7 High Yield Cy3 RNA Labeling Kit Workflow
2026-09-17
Build bright, reproducible RNA probes for in situ hybridization and Northern blotting with a tunable Cy3-UTP:UTP balance. This workflow also shows how probe-quality controls can inform interpretation of tumor-selective mRNA delivery research without confusing analytical labeling with therapeutic mRNA production.
-
Alda 1: ALDH2 Activator Workflows
2026-09-16
Alda 1 enables genotype-aware ALDH2 activation workflows spanning enzyme kinetics, cardiac stress models, and aldehyde detoxification studies. This practical guide connects the latest cardiomyocyte findings with assay setup, controls, troubleshooting, and research-use limitations.
-
Toremifene Citrate: Evidence, Methods, and Limits
2026-09-16
The reference paper presents toremifene citrate as a nonsteroidal antiestrogen and oral selective estrogen receptor modulator for postmenopausal patients with advanced hormone receptor-positive or unknown-status breast cancer. Its main contribution is a clinically oriented synthesis linking receptor pharmacology, comparative efficacy with tamoxifen, pharmacokinetics, safety monitoring, and treatment limitations relevant to breast cancer research.
-
U-73122: Phospholipase C Inhibitor Guide
2026-09-15
U-73122 is a phospholipase C inhibitor used to interrogate PLC-dependent calcium signaling, neutrophil chemotaxis, inflammation, and cancer-cell invasion. Product-reported benchmarks include an approximately 6 μM PLC-β2 IC50 and inhibition of inflammatory responses in rodent models, while peer-reviewed evidence connects U73122-sensitive PLC signaling with breast cancer invasiveness.
-
Recombinant Human IL-15 in Neuroimmune Assays
2026-09-15
Early life adversity research is revealing how developmental experience reshapes innate defensive behavior through oxytocin signaling. This thought-leadership article explains how Recombinant Human IL-15 can support rigorously controlled T-cell and NK-cell assays that add an immune dimension to translational neurobiology—without overstating what current evidence proves.
-
Thrombin B Fragment: A Decision Guide for Fibrin Assays
2026-09-14
Thrombin is a central trypsin-like serine protease, but its B chain fragment requires careful interpretation in fibrin and vascular assays. This guide distinguishes fragment identity from full-enzyme activity and translates fibrin-matrix evidence into practical experimental decisions.
-
NIH/3T3 Cells: Culture and QC Guide
2026-09-14
This guide translates the NIH/3T3 Cells product specifications into a practical recovery, expansion, assay-preparation, and quality-control workflow for researchers. The cells are appropriate for controlled fibroblast culture, cell transfection studies, viral proliferation research, and oncogene research, but the dossier does not establish quantitative assay performance, viral permissiveness, or clinical use.
-
Dabigatran Workflows for Thrombin Assays
2026-09-13
Dabigatran enables controlled, reversible thrombin inhibition across purified-enzyme, plasma, and coagulation function workflows. This practical guide connects assay design, solubility-aware preparation, parent–metabolite comparisons, and clinically relevant safety interpretation without treating research concentrations as dosing advice.
-
Trifluoperazine 2HCl: Assay Workflows & Tips
2026-09-12
Build more reliable dopamine D2 receptor, macrophage ROS/autophagy, and cancer-screening assays with a fresh-stock workflow for Trifluoperazine 2HCl. The article also shows how to separate receptor-proximal activity from downstream metabolic or cytotoxic phenotypes using controls, time courses, and orthogonal readouts.
-
Triacetin: From Metabolic Signal to Assay Design
2026-09-11
Triacetin, also called glyceryl triacetate, is more than a formulation excipient: it is a versatile biochemical perturbant linking acetate metabolism, AMPK signaling, HDAC biology, and cancer-cell phenotypes. This guide develops an evidence-aware framework for selecting concentrations, controls, and readouts without overstating experimental findings.
-
Lactylation–NSUN2 Drives PDAC Perineural Invasion
2026-09-11
This 2026 Theranostics study identifies NSUN2 K692 lactylation as a metabolic mechanism that strengthens perineural invasion in pancreatic ductal adenocarcinoma. By connecting lactate accumulation with m5C-dependent stabilization of CDCP1 and STC1 mRNAs, the work provides a mechanistic framework for studying tumor–nerve interactions and potential intervention points.
-
Preserving Phosphorylation in Placental SLE
2026-09-10
RSAD2 research in SLE pregnancy illustrates why phosphorylation-state preservation is a strategic requirement for translational biology. This article connects placental mechanism, pre-analytical rigor, and Phosphatase Inhibitor Cocktail 1 (100X in DMSO) to help researchers build more reproducible phosphoproteomic and biochemical workflows.
-
Dextran Sulfate Sodium Salt in DSS Colitis
2026-09-10
A translational framework for using Dextran sulfate sodium salt (MW 35000-45000) to connect epithelial injury, mucosal repair, and GPR35–KLF5 biology in preclinical colitis research.
-
Lypressin Acetate: From Receptor Biology to Translation
2026-09-09
Lypressin acetate, also known as Lysine vasopressin acetate, offers translational researchers a compact model for studying how peptide sequence, receptor breadth, route of administration, and assay context shape biological outcomes. This thought-leadership perspective connects vasopressin biology with experimental validation, diabetes insipidus research, vasoconstriction studies, and an appropriately cautious antiviral hypothesis.